Literature DB >> 22050907

Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma.

Jeffrey H Dunn1, Lixia Z Ellis, Mayumi Fujita.   

Abstract

The inflammasome is a multi-protein complex that mediates immune responses to microbial, host, and environmental signals. When active, inflammasomes regulate caspase-1 activation and IL-1β secretion. There is a strong link between inflammation and cancer, and IL-1β is one of the major molecules involved in both of these disease processes. Here we review the role of inflammasomes in regulating IL-1β secretion, and the impact of this pathway on cancer pathogenesis, with a focus on melanoma. This represents an exciting new area of research, and could potentially result in new targets for melanoma therapeutics in the future. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22050907     DOI: 10.1016/j.canlet.2011.10.001

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  53 in total

Review 1.  Integrating neuroimmune systems in the neurobiology of depression.

Authors:  Eric S Wohleb; Tina Franklin; Masaaki Iwata; Ronald S Duman
Journal:  Nat Rev Neurosci       Date:  2016-06-09       Impact factor: 34.870

Review 2.  Neurobiology of Resilience: Interface Between Mind and Body.

Authors:  Flurin Cathomas; James W Murrough; Eric J Nestler; Ming-Hu Han; Scott J Russo
Journal:  Biol Psychiatry       Date:  2019-04-17       Impact factor: 13.382

3.  Arsenic trioxide and other arsenical compounds inhibit the NLRP1, NLRP3, and NAIP5/NLRC4 inflammasomes.

Authors:  Nolan K Maier; Devorah Crown; Jie Liu; Stephen H Leppla; Mahtab Moayeri
Journal:  J Immunol       Date:  2013-12-13       Impact factor: 5.422

4.  Carboxyethylpyrroles: From Hypothesis to the Discovery of Biologically Active Natural Products.

Authors:  Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-11-02       Impact factor: 3.739

Review 5.  Molecular mechanisms underlying chronic inflammation-associated cancers.

Authors:  Yongzhong Wu; Smitha Antony; Jennifer L Meitzler; James H Doroshow
Journal:  Cancer Lett       Date:  2013-08-26       Impact factor: 8.679

6.  Interactome-wide analysis identifies end-binding protein 1 as a crucial component for the speck-like particle formation of activated absence in melanoma 2 (AIM2) inflammasomes.

Authors:  Li-Jie Wang; Chia-Wei Hsu; Chiu-Chin Chen; Ying Liang; Lih-Chyang Chen; David M Ojcius; Ngan-Ming Tsang; Chuen Hsueh; Chih-Ching Wu; Yu-Sun Chang
Journal:  Mol Cell Proteomics       Date:  2012-08-06       Impact factor: 5.911

7.  The clinicopathological and gene expression patterns associated with ulceration of primary melanoma.

Authors:  Rosalyn Jewell; Faye Elliott; Jonathan Laye; Jérémie Nsengimana; John Davies; Christy Walker; Caroline Conway; Angana Mitra; Mark Harland; Martin G Cook; Andy Boon; Sarah Storr; Sabreena Safuan; Stewart G Martin; Karin Jirström; Håkan Olsson; Christian Ingvar; Martin Lauss; Tim Bishop; Göran Jönsson; Julia Newton-Bishop
Journal:  Pigment Cell Melanoma Res       Date:  2014-10-01       Impact factor: 4.693

8.  NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases.

Authors:  Alenka Franko; Katja Goricar; Viljem Kovac; Metoda Dodic-Fikfak; Vita Dolzan
Journal:  J Med Biochem       Date:  2020-01-10       Impact factor: 3.402

Review 9.  Surgical inflammatory stress: the embryo takes hold of the reins again.

Authors:  Maria-Angeles Aller; Jose-Ignacio Arias; Isabel Prieto; Carlos Gilsanz; Ana Arias; Heping Yang; Jaime Arias
Journal:  Theor Biol Med Model       Date:  2013-02-01       Impact factor: 2.432

10.  NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway.

Authors:  Chaoqin Zhong; Ruiqing Wang; Mingqiang Hua; Chen Zhang; Fengjiao Han; Miao Xu; Xinyu Yang; Guosheng Li; Xiang Hu; Tao Sun; Chunyan Ji; Daoxin Ma
Journal:  Front Immunol       Date:  2021-06-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.